Cat. No. | Product name | CAS No. |
DCC1852 |
Dppe Hydrochloride
Substrate of CYP3A and inhibitor of P-glycoprotein |
92981-78-7 |
DCC1853 |
Dpre1-in-377790
Novel DprE1 inhibitor, killing M. tuberculosis |
634167-64-9 |
DCC1854 |
D-propargylglycine
Click chemistry tool molecule in probing peptidoglycan (PG) |
198774-27-5 |
DCC1855 |
Dp-v-4
Novel Dual PROTAC for Simultaneous Degradation of EGFR and PARP |
|
DCC1856 |
Dri-c23041
Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV |
|
DCC1857 |
Dri-c91005
Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV |
|
DCC1858 |
Dropropizine
Oral non-opioid anti-tussive agent for treatment of cough |
17692-31-8 |
DCC1859 |
Drostanolone Propionate
Inhibitor of the growth of estrogen receptor-presenting breast cancers |
521-12-0 |
DCC1860 |
Ds08210767
Novel potent PTHR1 antagonist |
2376334-75-5 |
DCC1861 |
Ds19161384
Novel selective PPARγ modulator, resulting in robust plasma glucose reductions with excellent DMPK profiles |
|
DCC1862 |
Ds28120313
Novel potent orally active hepcidin production inhibitor |
2146177-09-3 |
DCC1863 |
Ds37571084
Novel and orally bioavailable PTHR1 antagonist |
|
DCC1864 |
Ds-3801b Hydrochloride
Novel non-macrolide GPR38 agonist |
1369414-03-8 |
DCC1865 |
Ds42450411
Novel potent orally active hepcidin production inhibitor |
|
DCC1866 |
Ds79932728
Novel Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease |
|
DCC1867 |
Dsba Inhibitor F1
Pathogen motility inhibitor of EcDsbA |
859833-20-8 |
DCC1868 |
Dshs00884
Non-toxic human papillomavirus E6 inhibitor |
675104-49-1 |
DCC1869 |
Dsm-338
Novel Plasmodium falciparum Dihydroorotate Dehydrogenase (PfDHODH) Inhibitor (Pfalcip cells: 0.0018 μM) |
|
DCC1870 |
Dsm502
Featured
Novel potent inhibitor of dihydroorotate dehydrogenase (DHODH) |
2426616-55-7 |
DCC1871 |
Dsm705
Novel potent Dihydroorotate Dehydrogenase (DHODH) inhibitor |
2653225-38-6 |
DCC1872 |
Dsr-98776
Novel selective mGlu5 receptor negative allosteric modulator (NAM) with potent antidepressant and antimanic activity |
|
DCC1873 |
Ds-sg-44
Agonist of S1P receptors |